Impact of Deep Versus Standard Muscle Relaxation on Intra-operative Safety (EURORELAX)
Primary Purpose
Neuromuscular Blockade, Rocuronium, Anesthetics
Status
Recruiting
Phase
Not Applicable
Locations
International
Study Type
Interventional
Intervention
Deep neuromuscular block
Sponsored by

About this trial
This is an interventional treatment trial for Neuromuscular Blockade focused on measuring Laparoscopy
Eligibility Criteria
Inclusion Criteria:
- Patients scheduled for elective laparoscopic procedure with a complexity according to the BUPA classification for case complexity: 'MAJOR', 'MAJOR Plus or 'COMPLEX MAJOR'
- ASA (merican society of anesthesiologists) class I-III
- > 18 years of age
- Ability to give oral and written informed consent
Exclusion Criteria:
- Low or intermediate complexity laparoscopic procedures (BUPA 'SIMPLE' or 'INTER')
- Known or suspected neuromuscular disorders impairing neuromuscular function
- Allergies to muscle relaxants, anesthetics or narcotics mentioned in paragraph 5.2
- A (family) history of malignant hyperthermia
- Women who are or may be pregnant or are currently breast feeding
- Chronic use of any type of opioid or psychotropic drug
- Use of NSAID's shorter than 5 days before surgery
- Indication for rapid sequence induction
- Contra-indication for sugammadex use (e.g. known sugammadex allergy or Glomerular Filtration Rate <30 ml/min)
Sites / Locations
- Université De Lorraine
- Istituto Nazionale Dei Tumori
- RadboudUMCRecruiting
- LUMCRecruiting
- Noordwest ziekenhuis groep
- Netherlands Cancer instituteRecruiting
- Canisius Wilhelmina ZiekenhuisRecruiting
- Hospital Universitari I Politecnic La FeRecruiting
Arms of the Study
Arm 1
Arm 2
Arm Type
No Intervention
Experimental
Arm Label
Standard neuromuscular blockade
Deep neuromuscular block
Arm Description
Subjects will receive regular rocuronium induction dose, followed by bolus foses of 10 mg in case of insufficient conditions
Subjects will receive high dose rocuronium induction dose followed by continuous rocuronium administration, to achieve a depth of neuromuscular block of 1-2 twitches post tetanic count
Outcomes
Primary Outcome Measures
Classic score
To study the effect of deep neuromuscular block compared to standard neuromuscular block on intra-operative adverse events during laparoscopic surgery using the CLASSIC score system. (The Classic score; classification of intraoperative complications, is a 6 point scale ranging from no complications (0) to fatal complications (5).
Secondary Outcome Measures
L-SRS (Leiden Surgical Rating Scale)
To study the effect of deep neuromuscular block compared to standard neuromuscular block on peroperative surgical working conditions following the Leiden Surgical Rating scale (a 5 point scale, ranging from poor (1) to excellent (5) surgical conditions.
30 day post-operative complications
To study the effect of deep neuromuscular block compared to standard neuromuscular block on 30 day post-operative complications according the Clavien-Dindo score en Comprehensive Complication Index and unplanned readmissions
Quality of recovery (QoR)
To study the effect of deep neuromuscular block compared to standard neuromuscular block on Quality of Recovery at post-operative day 1, 2 according to the Quality of Recovery-40
Quality of life (QoL)
To study the effect of deep neuromuscular block compared to standard neuromuscular block on Quality of life at post-operative day 30 Short Form-36
Full Information
NCT ID
NCT04124757
First Posted
October 9, 2019
Last Updated
October 14, 2022
Sponsor
Leiden University Medical Center
Collaborators
Merck Sharp & Dohme LLC
1. Study Identification
Unique Protocol Identification Number
NCT04124757
Brief Title
Impact of Deep Versus Standard Muscle Relaxation on Intra-operative Safety
Acronym
EURORELAX
Official Title
The Impact of Deep Versus Standard Muscle Relaxation on Intra-operative Safety During Laparoscopic Surgery: a Multicenter Strategy Study
Study Type
Interventional
2. Study Status
Record Verification Date
October 2022
Overall Recruitment Status
Recruiting
Study Start Date
February 11, 2020 (Actual)
Primary Completion Date
September 1, 2023 (Anticipated)
Study Completion Date
March 1, 2024 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Leiden University Medical Center
Collaborators
Merck Sharp & Dohme LLC
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
Muscle relaxants are routinely applied during anesthesia to facilitate endotracheal intubation and to improve surgical working conditions. Several investigations have shown that a deep neuromuscular block (NMB) improves the surgical working conditions over a moderate NMB and effectively precludes sudden deterioration of the surgical field. However, whether the improvement of surgical working conditions translates into less intra- and postoperative complications remains uncertain. Small prospective or retrospective studies shown an decrease of the incidence of intraoperative adverse events and postoperative complications after a deep NMB. There is a need to confirm these outcome data prospectively, in a large number of patients and clinics and during a variety of surgical procedures.
Detailed Description
Muscle relaxants are routinely applied during anesthesia to facilitate endotracheal intubation and to improve surgical working conditions. Several investigations have shown that a deep neuromuscular block (NMB) (post tetanic count (PTC) 1-2 twitches) improves the surgical working conditions over a moderate NMB (TOF count 1-3 twitches) and effectively precludes sudden deterioration of the surgical field. However, whether the improvement of surgical working conditions translates into less intra- and postoperative complications remains uncertain. A recent retrospective analysis of neuromuscular management during laparoscopic retroperitoneal surgery showed a reduced rate of unplanned 30 day readmissions when a deep NMB over a moderate NMB was applied (3.8% vs. 12.7%).In addition, a pooled analysis of 4 randomized controlled trials comparing different levels of intra-abdominal pressure and neuromuscular blockade during laparoscopic donor nephrectomy, showed a significant reduction in the incidence of intra-operative surgical complications from 12.6% with moderate NMB to 4.8% with deep NMB.
These previous observations were made in small prospective or retrospective studies. There is a need to confirm these outcome data prospectively, in a larger prospective trial for a variety of surgical procedures. We therefore propose a multi-center, randomized controlled trial, to study the effect of a deep NMB (PTC 1-2 twitches) versus standard NMB (single induction dose rocuronium) in a variety of laparoscopic surgical procedures on the incidence of intraoperative adverse events and postoperative outcome data.
In this study the effect of deep neuromuscular block compared to standard neuromuscular block on intra-operative adverse events during laparoscopic surgery using the CLASSIC score system is evaluated.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Neuromuscular Blockade, Rocuronium, Anesthetics, Anesthesia Complication, Neuromuscular Blocking Agents, Surgery--Complications
Keywords
Laparoscopy
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare ProviderOutcomes Assessor
Allocation
Randomized
Enrollment
922 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Standard neuromuscular blockade
Arm Type
No Intervention
Arm Description
Subjects will receive regular rocuronium induction dose, followed by bolus foses of 10 mg in case of insufficient conditions
Arm Title
Deep neuromuscular block
Arm Type
Experimental
Arm Description
Subjects will receive high dose rocuronium induction dose followed by continuous rocuronium administration, to achieve a depth of neuromuscular block of 1-2 twitches post tetanic count
Intervention Type
Other
Intervention Name(s)
Deep neuromuscular block
Other Intervention Name(s)
High dose rocuronium
Intervention Description
Deep neuromuscular block will be achieved with high dose rocuronium to achieve a depth of 1-2 twitches post tetanic count
Primary Outcome Measure Information:
Title
Classic score
Description
To study the effect of deep neuromuscular block compared to standard neuromuscular block on intra-operative adverse events during laparoscopic surgery using the CLASSIC score system. (The Classic score; classification of intraoperative complications, is a 6 point scale ranging from no complications (0) to fatal complications (5).
Time Frame
Day of surgery
Secondary Outcome Measure Information:
Title
L-SRS (Leiden Surgical Rating Scale)
Description
To study the effect of deep neuromuscular block compared to standard neuromuscular block on peroperative surgical working conditions following the Leiden Surgical Rating scale (a 5 point scale, ranging from poor (1) to excellent (5) surgical conditions.
Time Frame
Day of surgery
Title
30 day post-operative complications
Description
To study the effect of deep neuromuscular block compared to standard neuromuscular block on 30 day post-operative complications according the Clavien-Dindo score en Comprehensive Complication Index and unplanned readmissions
Time Frame
30 postoperative days
Title
Quality of recovery (QoR)
Description
To study the effect of deep neuromuscular block compared to standard neuromuscular block on Quality of Recovery at post-operative day 1, 2 according to the Quality of Recovery-40
Time Frame
2 postoperative days
Title
Quality of life (QoL)
Description
To study the effect of deep neuromuscular block compared to standard neuromuscular block on Quality of life at post-operative day 30 Short Form-36
Time Frame
30 postoperative days
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Patients scheduled for elective laparoscopic procedure with a complexity according to the BUPA classification for case complexity: 'MAJOR', 'MAJOR Plus or 'COMPLEX MAJOR'
ASA (merican society of anesthesiologists) class I-III
> 18 years of age
Ability to give oral and written informed consent
Exclusion Criteria:
Low or intermediate complexity laparoscopic procedures (BUPA 'SIMPLE' or 'INTER')
Known or suspected neuromuscular disorders impairing neuromuscular function
Allergies to muscle relaxants, anesthetics or narcotics mentioned in paragraph 5.2
A (family) history of malignant hyperthermia
Women who are or may be pregnant or are currently breast feeding
Chronic use of any type of opioid or psychotropic drug
Use of NSAID's shorter than 5 days before surgery
Indication for rapid sequence induction
Contra-indication for sugammadex use (e.g. known sugammadex allergy or Glomerular Filtration Rate <30 ml/min)
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Gijsbert HM Honing, MSc
Phone
0031 71 526 2301
Email
g.h.m.honing@lumc.nl
First Name & Middle Initial & Last Name or Official Title & Degree
Chris Martini, PhD
Phone
0031 71 526 2301
Email
C.H.Martini@lumc.nl
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Monique van Velzen, PhD
Organizational Affiliation
LUMC
Official's Role
Principal Investigator
Facility Information:
Facility Name
Université De Lorraine
City
Nancy
State/Province
Meurthe-et-Moselle
ZIP/Postal Code
54000
Country
France
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Thomas Fuchs-Buder, Prof.
Phone
0033383153942
Email
t.fuchs-buder@chu-nancy.fr
Facility Name
Istituto Nazionale Dei Tumori
City
Milano
ZIP/Postal Code
20133
Country
Italy
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Franco Valenza, Prof.
Phone
0039 022 390 2282
Email
franco.valenza@istitutotumori.mi.it
Facility Name
RadboudUMC
City
Nijmegen
State/Province
Gelderland
ZIP/Postal Code
6525GA
Country
Netherlands
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Michiel C Warlé, PhD
Phone
0031 24 361 5333
Email
Michiel.Warle@radboudumc.nl
Facility Name
LUMC
City
Leiden
State/Province
Zuid-Holland
ZIP/Postal Code
2333ZA
Country
Netherlands
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Gijsbert Honing, PhD
Facility Name
Noordwest ziekenhuis groep
City
Alkmaar
ZIP/Postal Code
1815 JD
Country
Netherlands
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Margot Roozekrans, MD
Phone
0031 72 548 4444
Email
mhj.roozekrans@nwz.nl
Facility Name
Netherlands Cancer institute
City
Amsterdam
ZIP/Postal Code
1066 CX
Country
Netherlands
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Suzanne Broens, MD
Phone
0031 20 512 9111
Email
s.broens@nki.nl
Facility Name
Canisius Wilhelmina Ziekenhuis
City
Nijmegen
ZIP/Postal Code
6532 SZ
Country
Netherlands
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Ivo Panhuizen, MD
Phone
0031 24 365 7657
Email
ivopan@hotmail.com
Facility Name
Hospital Universitari I Politecnic La Fe
City
Valencia
ZIP/Postal Code
46026
Country
Spain
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Oscar D Cambronero, MD
Phone
0034 656 99 4108
Email
oscardiazcambronero@gmail.com
12. IPD Sharing Statement
Plan to Share IPD
Yes
IPD Sharing Plan Description
Protocol and SAP will be published before start study. CSR will be reported after article publication in a peer reviewed journal.
IPD Sharing Time Frame
Protocol and Statistical Analysis Plan will be published before start study. Clinical Study Report will be reported after article publication in a peer reviewed journal.
IPD Sharing Access Criteria
To be declared
Citations:
PubMed Identifier
29791482
Citation
Boon M, Martini C, Yang HK, Sen SS, Bevers R, Warle M, Aarts L, Niesters M, Dahan A. Impact of high- versus low-dose neuromuscular blocking agent administration on unplanned 30-day readmission rates in retroperitoneal laparoscopic surgery. PLoS One. 2018 May 23;13(5):e0197036. doi: 10.1371/journal.pone.0197036. eCollection 2018.
Results Reference
background
PubMed Identifier
27936214
Citation
Torensma B, Martini CH, Boon M, Olofsen E, In 't Veld B, Liem RS, Knook MT, Swank DJ, Dahan A. Deep Neuromuscular Block Improves Surgical Conditions during Bariatric Surgery and Reduces Postoperative Pain: A Randomized Double Blind Controlled Trial. PLoS One. 2016 Dec 9;11(12):e0167907. doi: 10.1371/journal.pone.0167907. eCollection 2016.
Results Reference
background
PubMed Identifier
24240315
Citation
Martini CH, Boon M, Bevers RF, Aarts LP, Dahan A. Evaluation of surgical conditions during laparoscopic surgery in patients with moderate vs deep neuromuscular block. Br J Anaesth. 2014 Mar;112(3):498-505. doi: 10.1093/bja/aet377. Epub 2013 Nov 15.
Results Reference
background
PubMed Identifier
25665678
Citation
Rosenthal R, Hoffmann H, Clavien PA, Bucher HC, Dell-Kuster S. Definition and Classification of Intraoperative Complications (CLASSIC): Delphi Study and Pilot Evaluation. World J Surg. 2015 Jul;39(7):1663-71. doi: 10.1007/s00268-015-3003-y.
Results Reference
background
PubMed Identifier
28969327
Citation
Madsen MV, Scheppan S, Mork E, Kissmeyer P, Rosenberg J, Gatke MR. Influence of deep neuromuscular block on the surgeons assessment of surgical conditions during laparotomy: a randomized controlled double blinded trial with rocuronium and sugammadex. Br J Anaesth. 2017 Sep 1;119(3):435-442. doi: 10.1093/bja/aex241.
Results Reference
background
PubMed Identifier
28643056
Citation
Ozdemir-van Brunschot DMD, Braat AE, van der Jagt MFP, Scheffer GJ, Martini CH, Langenhuijsen JF, Dam RE, Huurman VA, Lam D, d'Ancona FC, Dahan A, Warle MC. Deep neuromuscular blockade improves surgical conditions during low-pressure pneumoperitoneum laparoscopic donor nephrectomy. Surg Endosc. 2018 Jan;32(1):245-251. doi: 10.1007/s00464-017-5670-2. Epub 2017 Jun 22.
Results Reference
background
PubMed Identifier
15273542
Citation
Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004 Aug;240(2):205-13. doi: 10.1097/01.sla.0000133083.54934.ae.
Results Reference
background
PubMed Identifier
34702332
Citation
Honing M, Reijnders-Boerboom G, Dell-Kuster S, van Velzen M, Martini C, Valenza F, Proto P, Cambronero OD, Broens S, Panhuizen I, Roozekrans M, Fuchs-Buder T, Boon M, Dahan A, Warle M. The impact of deep versus standard neuromuscular block on intraoperative safety during laparoscopic surgery: an international multicenter randomized controlled double-blind strategy trial - EURO-RELAX TRIAL. Trials. 2021 Oct 26;22(1):744. doi: 10.1186/s13063-021-05638-2.
Results Reference
derived
Links:
URL
https://www.assessurgery.com/
Description
Link to calculate comprehensive complication index
Learn more about this trial
Impact of Deep Versus Standard Muscle Relaxation on Intra-operative Safety
We'll reach out to this number within 24 hrs